Closing the Loop in Adults With Sub-optimally Controlled Type 1 Diabetes Under Free Living Conditions

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Type 1 Diabetes
Interventions
DEVICE

Florence D2A or similar closed loop glucose control system

Subject's glucose level will be controlled by the Florence D2A or similar automated closed loop glucose control system. The system comprises of FreeStyle Navigator 2 ® Continuous Glucose Monitoring (CGM) System (Abbott Diabetes Care, Alameda, CA, USA), Dana R Diabecare subcutaneous insulin infusion pump (Sooil Corp. Seoul, South Korea)or similar insulin pump, and MPC-based glucose control algorithm running on a smartphone

DEVICE

CSII with real-time CGM

Subject glucose level controlled by usual insulin pump therapy in conjunction with real time continuous glucose monitoring (CGM)

Trial Locations (3)

A8036

Medical University of Graz, Graz

D41460

Profil Institut für Stoffwechselforschung GmbH, Neuss

CB2 0QQ

University of Cambridge, Cambridge

All Listed Sponsors
collaborator

Profil Institut für Stoffwechselforschung GmbH

INDUSTRY

collaborator

Medical University of Graz

OTHER

lead

University of Cambridge

OTHER

NCT01961622 - Closing the Loop in Adults With Sub-optimally Controlled Type 1 Diabetes Under Free Living Conditions | Biotech Hunter | Biotech Hunter